Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (531-540 of 723) with videos related to

Pageof 73
Sort By:
Endocrinology|July 1, 1981
Dissociated changes of pituitary luteinizing hormone-releasing hormone (LHRH) receptors and responsiveness to the neurohormone induced by 17 beta-estradiol and LHRH in vivo in the ratL Ferland, B Marchetti, C Séguin, et al.
Bulletin Der Schweizerischen Akademie Der Medizinischen Wissenschaften|March 1, 1978
[Specific role of sex steroids on the pituitary level. Sex steroids and anterior pituitary secretion]F Labrie, L Lagace, J Drouin, et al.
International Journal of Cancer|October 23, 1997
Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitroJ Simard, C Labrie, A Bélanger, et al.
International Journal of Cancer|February 1, 2000
Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude miceS Couillard, C Labrie, S Gauthier, et al.
The Prostate|May 1, 1994
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamideL Cusan, J L Gomez, A Dupont, et al.
Urology|February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenF Labrie, B Candas, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiencyM Zerah, E Rhéaume, P Mani, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiencyE Rhéaume, R Sanchez, J Simard, et al.
The American Journal of Anatomy|March 1, 1975
Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brainG Pelletier, R Leclerc, D Dube, et al.
British Journal of Urology|November 1, 1993
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinomaA Dupont, L Cusan, J L Gomez, et al.
Pageof 73

Showing results (531-540 of 723) with videos related to

Sort By:
Pageof 73
Endocrinology|July 1, 1981
Dissociated changes of pituitary luteinizing hormone-releasing hormone (LHRH) receptors and responsiveness to the neurohormone induced by 17 beta-estradiol and LHRH in vivo in the ratL Ferland, B Marchetti, C Séguin, et al.
Bulletin Der Schweizerischen Akademie Der Medizinischen Wissenschaften|March 1, 1978
[Specific role of sex steroids on the pituitary level. Sex steroids and anterior pituitary secretion]F Labrie, L Lagace, J Drouin, et al.
International Journal of Cancer|October 23, 1997
Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitroJ Simard, C Labrie, A Bélanger, et al.
International Journal of Cancer|February 1, 2000
Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude miceS Couillard, C Labrie, S Gauthier, et al.
The Prostate|May 1, 1994
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamideL Cusan, J L Gomez, A Dupont, et al.
Urology|February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenF Labrie, B Candas, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiencyM Zerah, E Rhéaume, P Mani, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiencyE Rhéaume, R Sanchez, J Simard, et al.
The American Journal of Anatomy|March 1, 1975
Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brainG Pelletier, R Leclerc, D Dube, et al.
British Journal of Urology|November 1, 1993
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinomaA Dupont, L Cusan, J L Gomez, et al.
Pageof 73